Interactions of heparin derivatives with recombinant human keratinocyte growth factor: Structural stability and bioactivity effect study. Issue 4 (2nd December 2022)

• Record Type: Journal Article
• Authors: Kalhor, Hourieh; Abolhasani, Hoda; Kalhor, Reyhaneh; komeili Movahhed, Tahereh; Rahimi, Hamzeh
• Is Part Of: Proteins. Volume 91:Issue 4(2023)
• Page Start: 542
• Page End: 554
• Publication Date: 2022-12-02
• Subjects: heparin -- low‐molecular weight heparin -- molecular docking -- molecular dynamic simulations -- palifermin -- recombinant human keratinocyte growth factor; Proteins -- Periodicals; Proteins -- Periodicals; 572.6
• DOI: 10.1002/prot.26448
• Languages: English
• ISSNs: 0887-3585

Abstract

Abstract: Heparin and heparan sulfate are important glycosaminoglycans that can regulate the activities of many vital proteins, especially the fibroblast growth factor (FGF) family. Because FGF7 (KGF) has an important role in tissue repair and maintaining the integrity of the mucosal barrier, recombinant human keratinocyte growth factor (rhKGF, palifermin) has been approved for the treatment of wound healing and oral cavity. Due to heparin plays an important role in the KGF signaling pathway, a more detailed study of the drug–drug interactions (DDIs) between rhKGF and heparin at the atomic level and investigating their synergistic effect on each other in terms of biology, especially in silico, is necessary for a better understanding of DDIs. In this study, DDIs between rhKGF and low‐molecular weight heparin types (LMWH) were investigated. In this regard, scrutiny of the influence of the synergistic heparin types on the structure and biostability of rhKGF is accomplished using computational methods such as molecular docking and molecular dynamic simulations (MDs). Subsequently, the motion behavior of rhKGF in interaction with LMWHs was evaluated based on eigenvectors by using principal component analysis (PCA). Also, the binding free energies of rhKGF‐LMWH complexes were calculated by the molecular mechanics/Poisson–Boltzmann surface area (MM‐BPSA) method. The result showed that rhKGF‐idraparinux (−6.9 kcal/mol) and rhKGF‐heparin (−6.0 kcal/mol) complexes had significant binding affinity as well as they had a more stable binding to rhKGF than to other LMWH during 100 ns simulation. However, in order to confirm the curative effect of these drugs, clinical trials must be done.